Polarization of Tumor-Associated Macrophages by Chinese Medicine Intervention: Mechanisms and Applications by Lu, Yuanjun et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Polarization of Tumor-Associated 
Macrophages by Chinese Medicine 
Intervention: Mechanisms and 
Applications
Yuanjun Lu, Hor Yue Tan, Ning Wang and Yibin Feng
Abstract
Macrophage polarization is a spectrum of phenotypes and generally can be 
classified into two states: (1) classically activated or M1 macrophages, which can 
be driven by lipopolysaccharide (LPS) alone or in association with Th1 cytokines 
and produce pro-inflammatory cytokines such as TNF-α, IL-6 and, IL-12, and (2) 
alternatively activated M2 macrophages, which can be promoted by Th2 media-
tors IL-4 and IL-13 and produce anti-inflammatory cytokines such as TGF-β and 
IL-10. Current studies have found that the phenotypic switch between M1 and M2 
macrophages governs the fate of an organ in inflammation or injury. The imbalance 
of M1/M2 polarization is closely involved in various pathological processes and is 
becoming a potential target for therapeutic strategies. Traditional Chinese medicine 
is an integrated healthcare system composed of many practices and is characterized 
by multi-target, multi-level, and coordinated intervention effects. Chinese medi-
cines nowadays are applied to regulate phenotype polarization of macrophages to 
improve the microenvironment, thus ameliorating or even eliminating the symp-
toms. In this chapter, we will discuss the molecular mechanisms of macrophage 
polarization, their roles in health and disease, and the intervention with Chinese 
medicines to modulate the polarization of macrophages in tumor microenviron-
ment (TME) for therapeutic purpose.
Keywords: tumor microenvironment, tumor-associated macrophage, polarization, 
Chinese medicine
1. Introduction
Primary and metastatic tumors are generally known as a complex ecosystem 
containing tumor cells and the surrounding environment, called tumor micro-
environment (TME). Apart from autonomous changes by genetic alteration of 
tumor cells, the dynamic changes of TME progress the tumor progression [1]. 
TME is a multifaceted pool that consists of various cell types including neoplastic 
cells, stromal cells, and immune cells that interact with one another via numerous 
secreted cytokines, growth factors, and chemokines. Tumor-associated macro-
phages (TAMs) take up a large portion of recruited immune cells and constitute up 
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to 50% of the tumor mass. It was reported that the high level of TAMs is associated 
with poor prognosis and decreasing overall survival in many cancers, such as liver, 
breast, gastric, and thyroid cancers, suggesting that TAMs certainly play essential 
roles during tumor development [2–6].
TAM recruitment and accumulation are regulated by various cytokines and 
chemokines, such as CCL2, CCL5, CCL7, CXCL12, etc., and growth factors includ-
ing VEGF, PDGF, and CSF1, as well as other factors such as fibronectin and 
fibrinogen [7–10]. CSF1 is the major regulator for monocyte proliferation and 
differentiation. CCL2 is a dominant attractant in many tumors. Since monocytes 
highly expressed the receptor of CCL2 (CCR2), most of tumors produced a high 
level of CCL2 that can intensely attract monocytes migrating toward CCL2-CCR2 
axis [11–17]. However, CCL2 inhibition studies show that it could not completely 
suppress TAM accumulation, indicating that other factors affect this process [7, 
17–21]. The CCL12-CXCR4 axis is reported to promote TAM regional accumulation 
under therapeutic treatments. In mice model, breast cancer highly expressed CCL20 
and CCL5; Either inhibited CCL20 expression or treated with CCR5 antagonist, 
the number of TAMs was significantly reduced within tumors. These studies have 
shown that in breast cancer, CCL20-CCR6 and CCL5-CCR5 axes contribute to TAM 
accumulation. Another chemokine CCL11 can be induced under hypoxia condition 
and subsequently recruit TAMs to the hypoxic region.
In turn, TAMs can produce different molecules to remodel TME and influence 
fundamental aspects of tumor pathology. For instance, TAMs secrete endothelial 
growth factor (EGF) to increase neoplastic proliferation directly [22]; TAMs release 
vascular endothelial growth factors (VEGF) [23], angiogenic factor thymidine 
phosphorylase, and other chemokines including CCL2 and CXCL8 to enhance 
angiogenesis; TAMs produce metalloproteases (MMPs) to change TME matrix 
architecture for tumor metastasis [24]; and TAMs express immune regulatory mol-
ecules such as arginase-1 (ARG1), IL-10, and IL12 to modulate immune response 
[2]. The role of TAMs is accomplished by their phenotypic plasticity, either pro-
inflammatory or anti-inflammatory phenotype, in response to the complex stimuli 
in TME. The double-edged sword feature of TAM polarization makes them as a 
novel and potent target for cancer prevention and treatments.
Traditional Chinese medicine is an integrated healthcare system composed of 
many practices that were rooted in China for over 5000 years. Due to its multi-
target, multi-level, and coordinated intervention effects, Chinese medicine is 
widely used for therapeutic strategies. Recent studies reported that some of the 
Chinese herbal medicines have beneficial effects on cancer therapy via modulating 
TAM polarization, indicating a new mechanism for Chinese medicine treatment. 
In this chapter, we will explore the molecular mechanisms of TAM polarization and 
their roles in health and disease, and we will review the intervention by some of the 
Chinese herbal medicines on TAM polarization.
2. TAM polarization and molecular mechanisms
2.1 TAM polarization
It is widely accepted that the majority of TAMs are derived from circulat-
ing monocytes via cytokine recruitment and then differentiate to macrophages. 
And those at the metastatic sites are called metastatic-associated macrophages 
(MAMs) according to their location [25]. While recent studies have shown that 
the tissue-resident macrophages also contribute to TAM population [26, 27], these 
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progenitors, also called embryonic macrophages, are derived from the yolk sac or 
fetal liver-derived progenitors, and they can maintain themselves by local prolif-
eration in a hematopoietic system-independent way [28]. The selective depletion 
studies found that only the tissue-resident macrophages support the established 
tumor growth. Therefore, TAMs are heterogeneous cell populations from both 
tissue-resident macrophages and monocyte-derived macrophages and assist TME 
remodeling.
Besides their heterogeneity, TAMs are also characterized by high plasticity. In 
the general regard, macrophages can be overgeneralized to two extreme subsets 
based on the stimuli, surface markers, and secreted molecules, as well as functional 
properties: the classically activated M1 and alternatively activated M2 macro-
phages. The M1 phenotype is induced by the Th1 cytokine interferon-γ (IFN-γ), 
bacterial moieties such as lipopolysaccharide (LPS), and Toll-like receptor (TLR) 
agonists. The M1 macrophages are characterized by their capacity to produce 
inflammatory cytokines (e.g., IL-6, IL-1, IL-12, IL-23, and TNF-α) and stimulate 
immune response, express reactive oxygen species (ROS) and inducible nitric oxide 
synthase (iNOS), and have a cytotoxic effect toward neoplastic cells and phago-
cytic microorganisms [29–34]. Generally, the M1-like macrophages act as sentries 
and display tumoricidal function, antimicrobial activity, and tissue destruction 
effect [33, 35].
In contrast, the M2 phenotype is promoted by Th2 mediators and produces 
immunosuppressive factors (e.g., IL-10, TGF-β) and growth factors (e.g., VEGF) 
and exerts anti-inflammatory and pro-tumorigenic activities [34, 36, 37]. Moreover, 
the M2-like macrophages can be further subdivided into three categories, M2a, 
M2b, and M2c, based on the type of stimuli. The M2a macrophages are driven by 
type II cytokines including IL4 and IL13 and expressed a high level of arginase-1; 
M2b macrophages are activated by immune complexes/TLR, while M2c macro-
phages by anti-inflammatory cytokines (e.g., IL-10) and glucocorticoids [38]. The 
M2-like macrophages promote angiogenesis, wound repair, and tumor growth, as 
well as resistance to parasitic infection. Many studies reported that TAMs mostly 
represent M2-like macrophages and play pro-tumoral roles.
2.2 Molecular mechanisms in regulating TAM polarization
2.2.1 The JNK signaling pathway
The c-Jun N-terminal kinase (JNK) proteins are a group of stress-activated 
serine threonine protein kinases of the MAPK and can be activated by various 
external stimuli including inflammatory cytokines, environmental stresses, growth 
factors, and GPCR agonists. The outside signals can be transduced by small GTPase 
to MAP3Ks and further activate MKK4/7. The MAP3Ks play key roles in the JNK 
pathway and affect tremendous downstream transcription factors including AP-1, 
Smad3, and STAT3, thus controlling many biological processes [39]. The studies 
on adipose tissue macrophages (ATMs) have demonstrated that the JNK pathway 
is indispensable in regulating M1/M2 phenotype formation. In HFD-/NAFLD-
induced inflammation and obesity, the activated JNK pathway can promote the 
expression of the M1-associated genes via CCR2 and NF-κB signaling. The M1-like 
ATMs are related to the resistance to insulin [40, 41]. Recent studies found that nor-
mal adipocytes produce Th2 cytokines, such as IL-13 and IL-4 which can enhance 
M2-like macrophage polarization via activating STAT6 and PPAR𝛿/𝛽, as well as ACE 
to block the JNK pathway-induced M1-like phenotype [42]. Studies also found that 
vigorous exercise can promote M2 state through decrease phosphor-JNK [43].
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2.2.2 The PI3K/Akt signaling pathway
Among different pathways, the PI3K/Akt pathway is playing a central role in 
regulating polarized phenotype alteration. It can be activated by many stimuli such 
as TLR4, PRRs, FcRs, and cytokines and modify downstream cytokine production 
[44–47]. In turn, the PI3K/Akt pathway can affect the expression of stimuli and 
form a feedback loop. For example, the activated PI3K/Akt pathway can inhibit 
the transcription factors of TLR4 including TRAF6 and FOXO1 either directly or 
indirectly to suppress TLR4 stimulation. The PI3K has two transducers PIP2 and 
PIP3 which exert opposite functions during stimulation. It has been reported that 
PIP2 can enlarge LPS-induced M1-like macrophage polarization, while PIP3 can 
target mTORC2 via Akt recruitment and promote M2-like macrophage polariza-
tion. Other studies found that PTEN and SHIP play an inhibitory effect on PI3K/
Akt transduction by transforming PIP3 to PIP2. The downstream signals mTORC1 
and mTORC2 also participate in regulating M1/M2 alteration. Deletion of TSC1 can 
promote LPS-induced M1 polarization and inhibit IL-4-triggered M2 polarization 
via inhibiting mTORC1-induced Akt signaling, while the deletion of TSC2 gives an 
opposite response. Furthermore, the isoforms of Akt also contribute to influence 
the M1-/M2-polarized phenotype transformation in the opposite way. In knocked 
out Akt1, the expressions of iNOS and IL-12 were enhanced which is a hallmark of 
M1-like macrophages, and the transcription factor C/EBPβ of M2-related genes was 
decreased. The deletion of Akt2 led to C/EBPβ and M2 markers enhanced, includ-
ing Arg1, Fizz1, and Ym1 [48].
2.2.3 The JAK/STAT signaling pathway
The JAK/STAT pathway is one of the principle regulators for transducing 
different signals and affects various gene expressions. The JAK family consists of 
JAK1–3 and TYK2 and can be recruited and bind to the intracellular domains of 
activated receptors. JAKs will subsequently become dimers after autophosphory-
lation and then phosphorylate their downstream STAT family which has seven 
members including STAT1–4, STAT5A/B, and STAT6. The activated STAT family 
will translocate to the nucleus and modulate the expression of their target genes 
[49]. Increasing evidence found that the JAK/STAT pathway is closely related to 
M1/M2 phenotypic polarization. Among different stimuli of JAK/STAT signaling 
pathway, the IFN-γ has been known as a strong inducer of M1 phenotype through 
STAT1 activation [50]. It is controlled by IRF5 and IRF4 which exert promotive 
and inhibitory effects, respectively [51]. The IL-4 and IL-10 can activate STAT3 
and STAT6 to program the M2-like phenotype and also have cross talk with JNK 
pathway as mentioned in the JNK signaling pathway. The IL-13 can activate both 
M1- and M2-associated genes through STAT1, STAT3, and STAT6 activation [52]. 
There are two regulators of JAK/STAT pathway that affect M1/M2 reprogram-
ming, SOCS1 and SOCS3. The SOCS1 exhibits a suppressive function on STAT1, 
thus leading to the M1-like phenotype inhibition, while activating STAT6 to 
induce M2 polarization. The SOCS3 can activate STAT1 activity to contribute M1 
polarization [53, 54].
2.2.4 The Notch signaling pathway
The Notch pathway is generally known to play a fundamental role in regulating 
development and assist to govern the fate in response to different stimuli. There are 
four members of transmembrane receptors including Notch1–4. When the Notch 
receptors bind to their ligand family, such as Delta-like proteins (DLLs) and Jagged 
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proteins, the Notch intracellular domain (NICD) receptors will be released into the 
cell nucleus and binds to RBP-J to form a transcription complex, thus driving the 
target gene expression [55]. For example, LPS stimulation can upregulate DLL4 
which is one of the DLLs in the TLR4/NF-κB-dependent way. The increased DLL4 
can lead to activated Notch signaling and induce pro-inflammatory genes, such as 
IL-12 and iNOS [56]. Apart from the direct function of RBP-J, it can also positively 
regulate IRF8 activation to promote pro-inflammatory cytokine production. And 
this regulation is associated with PI3K/Akt and TLR4/NF-κB pathways [57].
2.2.5 Other molecular mechanisms
Apart from the signaling pathways mentioned above, there are many other path-
ways involving in M1/M2 reprogramming. For example, the TLR/NF-κB pathway is 
important in regulating the innate immune response. TLRs can sense the microbial 
components and transduce signals to affect NF-κB activity. When the NF-κB is 
formed as p50/p65, it promotes M1-associated gene expression, while p50/p50 form 
has beneficial effects on M2-associated gene expression [58, 59]. It is worth noting 
that the hypoxia-dependent pathway also participates in M1/M2 phenotypic switch. 
The HIF-1α is induced under hypoxia condition and serves as a transcription factor 
to regulate protein production. It has been reported that HIF-1α promotes M1-like 
polarization by enhancing iNOS production and HIF-2α promotes M2 phenotype 
via increasing Arg-1 expression [60].
3. Roles of TAM polarization and Chinese medicine intervention
The roles of TAMs under physiological and pathological conditions depend on 
their dichotomic polarization. Generally, when infection of tissue or damage occurs, 
The first-responding TAMs show M1-like phenotype and secrete pro-inflammatory 
cytokines to defend against invading pathogens and eliminate necrotic cells. And at 
the latter stage, the M2-like macrophages have shown as a compensation mechanism 
to prohibit extensive inflammation and assist in wound healing. In cancers, the 
M1-like TAMs predominantly exert cytotoxicity effect on cancer cells, while the 
M2-like TAMs assist in modulating immunosuppressive and pro-tumoral TME for 
cancer progression. Nowadays, TAMs are becoming promising targets for thera-
peutic strategies [61, 62]. Many Chinese herbal medicines have been identified to 
have anti-microbial, anti-inflammatory, immune regulatory, and antitumor effects. 
It would be interesting to review the intervention of Chinese medicines on TAM 
polarization in different cancers and diseases. Here, we select some of the Chinese 
medicines to describe as examples.
3.1 Baicalein
Baicalein (5,6,7-trihydroxyflavone) is isolated from the Chinese herb Scutellaria 
baicalensis root and has many beneficial effects on antitumor, anti-inflammation, 
anti-fibrosis, and antimicrobial [63, 64]. The treatment of baicalein in breast cancer 
is the first to explain its effect on TAM regulation. In breast cancer, TAMs showed 
M2-like phenotype that produced TGF-β1 and enhanced tumor growth and EMT 
process via PI3K/Akt signaling pathway. In turn, the tumor cells secreted TGF-β1 to 
maintain TAMs in M2-like phenotype. The positive feedback loop between tumor 
cells and M2-like macrophages was formed and further contributed to tumor metas-
tasis in the lung. Baicalein administration could block TGF-β1 via inhibiting PI3K/
Akt pathway. Besides, instead of altering the population of TAMs, baicalein could 
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drive M2-like macrophages to M1-like macrophage differentiation, with M1 markers 
increased. Therefore, the application of baicalein in regulating TAM polarization in 
breast cancer may provide a new understanding of other cancer treatments [65].
3.2 Panax notoginseng
The root of Panax notoginseng (PN) (Burk.) F.H. Chen is one of the popular 
Chinese herbs also known as sanqi, tianqi, or sanchi in Asia [66]. It has been widely 
used in many disorders for over 400 years due to its anticancer, anti-inflammatory, 
antiatherosclerotic, and hemostatic properties [67, 68]. Recent studies have shown 
that PN not only has cytotoxicity on cancer cells but also can redirect TAM polariza-
tion. It is commonly known that M2-like macrophages exert pro-tumorigenic effects 
on cancer, and to redirect M2 phenotype to antitumor M1 phenotype would be one 
of the promising strategies in cancer treatment. In many lung cancer studies, it has 
been reported that high doses of PN administration have direct cytotoxic effects 
on cancer cells, while the lower dose of PN still have inhibitory effects on tumor 
growth, suggesting there are other regulatory mechanisms. The in vitro study found 
that a lower dose of PN did not affect cancer cells, but it could reeducate M2-like 
macrophages toward M1 phenotypic differentiation [69]. It would help to better 
explain the pharmacological mechanism of PN.
3.3 Osthole
Osthole [7-methoxy-8-(3-methyl-2-butenyl)-2H-1-benzopyran-2-one] is isolated 
from Cnidium monnieri (Fructus Cnidii) and belongs to coumarin family, which is a 
benzopyrone and used as tumor-target drug carrier [70]. Osthole not only has cyto-
toxicity to cancer cells, such as breast cancer, lung cancer, HCC, and nasopharyngeal 
cancer (NPC) [71–73], but also has immunomodulatory effects on different tumors. 
In pancreatic tumors, osthole decreased M2-like macrophage population both in 
tumor site and spleen. But it did not affect M1-like macrophages. An in vitro study 
found that osthole could significantly inhibit STAT6 pathway and p-ERK1/2-C/EBP 
β signal, thus further inhibiting the M2-like macrophage polarization [74].
3.4 Emodin
Emodin (1,3,8-trihydroxy-6-methylanthraquinone) is a natural anthraquinone 
derivative from many Chinese herbs, and it has multiple pharmacological effects 
[75]. One study focused on the effects of emodin on macrophage polarization has 
shown that it could bidirectionally regulate both M1 and M2 phenotype programs 
via different signaling pathways, as well as participated in the epigenetic modifica-
tion. It seems like that emodin can restrain excessive M1- or M2-like macrophages 
and assist in maintaining homeostasis in different pathologies. For example, in 
breast cancer, emodin decreased TAM infiltration and inhibited M2-polarized phe-
notype by suppressing STAT6 and C/EBPβ signaling pathway. Moreover, it could 
increase H3K27m3 to downregulate M2-related genes.
3.5 Other Chinese medicine
Many other Chinese medicines have protective functions on different diseases 
through regulating M1/M2 phenotypic switch (as shown in Table 1). For example, 
curcumin can promote macrophages toward M2-like phenotype to ameliorate 
liver fibrosis, and it also assists wound healing [76]. Smiglaside A and Ginsenoside 
Rb3 have protective functions against acute lung injury via inducing M2-like 
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macrophage polarization [77, 78]. These findings may throw a new light for the 
regulatory mechanisms of Chinese medicines and promote their applications in 
health and diseases.
Chinese medicine M1/M2 phenotype 
switch
Disease Reference
Angelica sinensis M2 Cardiac fibrosis [79]
Baicalein M1 Breast cancer [65]
Berberine M2 Colitis; insulin resistance [80, 81]
Bergenin M2 Colitis [82]
Celastrol M2 Diet-induced obesity; acute 
ischemic stroke
[83, 84]
Corilagin M1 Schistosome egg-induced 
hepatic fibrosis
[85]
Crocin M2 Atherosclerosis [86]
Curcumin M2 Liver fibrosis; wound healing [76, 87]
Dioscin M1 Melanoma [88]
Diosgenin glucoside M2 Neuroinflammatory diseases [89]
Emodin M1 Breast cancer [90]
Ganoderma lucidum Karst M1 Inflammation [91]
Gastrodin M2 Cerebral palsy [92]
Ginkgolide B M2 Ischemic stroke [93]
Ginsenoside Rb1 M2 Atherosclerosis [94]
Ginsenoside Rb3 M2 Acute lung injury [78]
Isoliquiritigenin M2 Acute kidney injury [95]
Kumatakenin M1 Ovarian cancer [96]
Magnesium lithospermate 
B
M2 Neuronal injury [97]
Mylabris phalerata M1 Lung carcinoma [98]
Osthole M1 Pancreatic cancer [74]
Paeoniflorin M2 Neuronal injury [99]





M2 Inflammatory bowel disease [101]
Pterostilbene M1 Lung cancer [102]
Punicalagin M2 Inflammation [103]
Saponin M2 Intestinal polyps [104]
Smiglaside A M2 Acute lung injury [77]
Tanshinone IIA M2 Acute kidney injury
Inflammation
[105]
Timosaponin AIII M2 Colitis [106]
Trichosanthes Kirilowii 
lectin




The intervention of Chinese medicine on M1/M2 switch in different diseases.
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4. Conclusions
Current studies have described the heterogeneity and adaptive plasticity of TAMs 
in the intrinsic and dynamic TME. They are composed of both tissue-resident macro-
phages and monocyte-derived macrophages and interplay with TME. The latter one is 
attracted and recruited to the tumor site via various signals in TME, while TAMs can 
produce different molecules to remodel TME. In response to different stimuli, TAMs 
can differentiate into either classically activated/M1 macrophages or alternatively 
activated/M2 macrophage which involves multiple signaling pathways. The role of 
TAMs depends on their dichotomic polarization in health and disease. Therefore, they 
are becoming potential targets for many therapeutic strategies. Chinese medicine 
has been widely used in a long history of Asia and shows multiple effects on different 
diseases. Knowing the intervention of Chinese medicine on TAMs polarization may 
help to better understand the principle of Chinese medicine and contribute to the 
comprehensive applications in many diseases.
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AP-1 activator protein 1
ARG1 arginase-1
ATM adipose tissue macrophage
CCR C-C motif chemokine receptors
CSF1 colony stimulating factor
DLL Delta-like protein
EGF endothelial growth factor
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HIF hypoxia inducible factor
IFN interferon
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MAM metastatic-associated macrophage
MAPK mitogen-activated protein kinase
MMP metalloprotease
mTOR mammalian target of rapamycin
NAFLD nonalcoholic fatty liver disease
NICD intracellular domain of notch receptor
NPC nasopharyngeal cancer





PPAR peroxisome proliferator-activated receptor
PRR pattern recognition receptor
RBP-J recombination signal binding protein for immunoglobulin Kappa J 
region
ROS reactive oxygen species
Smad3 SMAD family member 3
SOCS suppressor of cytokine signaling
STAT signal transducer and activator of transcription
TAM tumor-associated macrophages
TGF transforming growth factor
Th1 type 1 T helper
Th2 type 2 T helper
TLR Toll-like receptor
TME tumor microenvironment
TRAF TNF receptor-associated factor
VEGF vascular endothelial growth factor
Ym1 chitinase-like 3
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